Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active Surveillance

NCT03956108 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST: MRI+targeted biopsies+Stockholm3-test
DIAGNOSTIC_TEST: PSA + systematic biopsies

Sponsor

Karolinska Institutet